The funding round will enhance and broaden the reach and capacity of the company's mobile app designed to help users overcome insomnia.
Category: Cognitive Behavioral Therapy
The digital sleep program, which uses CBT-I-based strategies and text-based coaching, showed meaningful improvements in total sleep time for users in a new study.Read More
Nox Health Group is set to acquire Pear Therapeutics’ Somryst after being selected as the successful bidder at Pear’s bankruptcy auction last week.Read More
Teach patients these relaxation exercises as part of their insomnia therapy.Read More
The COVID-19 pandemic offered researchers a rare opportunity to see the effects of a potentially distressing global event on people with sleep reactivity, that is, those who are vulnerable to stress-related sleep disturbances.Read More
Jennifer L. Martin, PhD, speaks about the challenges faced by people with insomnia disorder in accessing CBT-I and pharmaceuticals, as well as posits solutions.Read More
A paper details a health economic analysis of Somryst, including changes in healthcare resource use, associated costs, and insomnia severity.Read More
ResMed Acquires Mementor. Its Insomnia Solution Builds ResMed’s Digital Sleep Medicine Portfolio in Germany.
ResMed has acquired Leipzig, Germany-based health tech company mementor; the deal was completed on August 1.Read More
Insomnia is linked with anxiety and depression, and a clinical trial evaluates the impact of Somryst on these comorbidities.Read More
Hundreds of thousands of insomnia patients will be offered digital cognitive behavioral therapy via the app Sleepio instead of sleeping pills.Read More
Two abstracts presented at World Sleep 2022 provide data on Somryst’s efficacy at six months and on its use in older adults.Read More
By targeting insomnia and effectively treating it with CBT-I, depression can be effectively prevented by over 50% in community dwelling older adults with insomnia.Read More
SleepCogni, Developers of Insomnia Device with Cognitive Behavioral Therapy Platform, Raises $2M to Enter US Market
The investment will help prepare the device for volume manufacturing, develop the clinician and patient-led online platform, and achieve first sales.Read More